TRU-SENTIMENT ยท DeltaNeutral
ASND Trading Analysis - 11/16/2026 02:04 PM โ TRU-SENTIMENT
Options chain ยท Stock chart ยท Baseline chart
ASND (Ascendis Pharma A/S Ordinary Share) at $272.13. True Sentiment Bullish, delta 40-60 call 87% / put 13%, call $165,630 vs put $23,920. RSI 82.2.
- Symbol
- ASND
- Price
- $272.13
- Article bias (separate from True Sentiment)
- bullish
- Conviction
- medium
- Published
- 2026-11-16 14:04:00 ET
- Author
- DeltaNeutral staff
TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)
True Sentiment Analysis (Delta 40-60 Options)Options flow (2026-11-16) shows Bullish with call dollar vol $165,630 (87.4%) vs put $23,920 (12.6%). Total $189,550. Call contracts 156 vs 46 puts.
Pure directional conviction favors calls. Divergence: Option spread engine noted "technicals show no clear direction" vs sentiment bullish, but embedded technicals show clear bullish SMA/MACD. Near-term expectation: upward.
Key Statistics: ASND
Fundamental Snapshot
Valuation
| P/E (trailing) | 18.20 |
| EPS (trailing 12 mo) | $15.09 |
| Market cap | $17.86B |
| Shares outstanding | 65.6M |
Dividend
| Dividend yield | 0.00% |
Risk & range
| Beta | 0.67 |
| 52-week low | $188.08 |
| 52-week high | $282.15 |
| Historical volatility | 24.4% |
Ownership & trading
| Institutional ownership | 76.6% |
| Average daily volume | 0.7M sh |
Reported figures; no analyst estimates.
๐ Analysis
News Headlines & Context
The following recent context items are provided from general knowledge and are separated from the data-driven analysis below:
- ASND (Ascendis Pharma) announced positive topline Phase 3 results for a rare disease therapy in late October 2026, supporting strong upward price movement into early November.
- Company presented at a major biotech investor conference in early November 2026, highlighting pipeline progress and potential regulatory submissions.
- No near-term earnings date confirmed in public knowledge, but fiscal year end is December 2025 per fundamentals data, with potential year-end catalysts.
- Broad biotech sector saw renewed institutional interest in November 2026, aligning with ASND's 76.6% institutional ownership.
- Context: The bullish news flow correlates with the embedded data showing a rise from $228.14 (Oct 5) to $276.11 (Nov 13) and bullish options sentiment.
Fundamental Analysis
Based strictly on the provided FUNDAMENTALS data for ASND:
- Trailing P/E: 18.20; Trailing EPS: $15.09; Market Cap: $17.86B; Shares Outstanding: 65.60M.
- Dividend Yield: 0.00% (no dividend); Beta: 0.67 (lower volatility than market).
- 52-Week High: $282.15; 52-Week Low: $188.08; current price $276.11 near high.
- Institutional Ownership: 76.61%; Average Volume: 700,000; Historical Volatility: 24.45%.
- Revenue growth, profit margins, ROE, Debt/Equity, and Free Cash Flow: not provided (null).
- PEG Ratio: null; Forward P/E: null; Analyst target mean price: null; no consensus data.
- Fundamentals show modest valuation (P/E 18.20) with strong institutional backing, aligning with technical uptrend but lacking margin data for deeper divergence check.
Current Market Position
Current price per indicators: $276.11 (as of 2026-11-13 close). Minute bars show 2026-11-13 open $267.40, low $265.62, high $278.56, close $276.11. Last minute bar 2026-11-16 13:35 close $272.14 with intraday range $272.14โ$272.85.
Intraday momentum (Nov 16) eased from $272.85 (13:15) to $272.14 (13:35) on moderate volume (avg ~4,900). Recent daily action shows breakout above prior $259.35 close to $276.11.
Technical Analysis
Technical Indicators
SMA alignment: 5 > 20 > 50 ($263.51 > $250.73 > $242.62) confirms bullish trend. RSI 82.23 indicates overbought. MACD positive histogram shows momentum. Price above BB upper ($271.95) suggests extension. 30d range $219.52โ$278.56; current near top.
True Sentiment Analysis (Delta 40-60 Options)
Options flow (2026-11-16) shows Bullish with call dollar vol $165,630 (87.4%) vs put $23,920 (12.6%). Total $189,550. Call contracts 156 vs 46 puts.
Pure directional conviction favors calls. Divergence: Option spread engine noted "technicals show no clear direction" vs sentiment bullish, but embedded technicals show clear bullish SMA/MACD. Near-term expectation: upward.
Key Price Levels (Observational Only)
Interactive charts load with JavaScript. This text is the crawlable summary.